{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:39:04Z","timestamp":1779917944963,"version":"3.53.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":206,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.rmcr.2022.101723","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T06:03:56Z","timestamp":1660716236000},"page":"101723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: A case report"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6197-5176","authenticated-orcid":false,"given":"Yoshiro","family":"Kai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Tanimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.rmcr.2022.101723_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin. Exp. Allergy: J. Br. Soc. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmcr.2022.101723_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.alit.2015.05.007","article-title":"Sensitization to fungal allergens: resolved and unresolved issues","volume":"64","author":"Fukutomi","year":"2015","journal-title":"Allergol. Int.: Off. J. Japanese Soc. Allergol."},{"key":"10.1016\/j.rmcr.2022.101723_bib3","volume":"vol. 14","author":"Eraso","year":"2020"},{"key":"10.1016\/j.rmcr.2022.101723_bib4","volume":"vol. 12","author":"Lewington-Gower","year":"2021"},{"issue":"26","key":"10.1016\/j.rmcr.2022.101723_bib5","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.rmcr.2022.101723_bib6","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.12998\/wjcc.v9.i23.6922","article-title":"Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: a case report","volume":"9","author":"Nishimura","year":"2021","journal-title":"World J.Clin. cases."},{"issue":"4","key":"10.1016\/j.rmcr.2022.101723_bib7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"Asano","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmcr.2022.101723_bib8","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3389\/fimmu.2018.02346","article-title":"Allergic bronchopulmonary aspergillosis-A luminal hypereosinophilic disease with extracellular trap cell death","volume":"9","author":"Ueki","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.rmcr.2022.101723_bib9","article-title":"Mepolizumab as possible treatment for allergic bronchopulmonary aspergillosis: a review of eight cases","volume":"12","author":"Tolebeyan","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.rmcr.2022.101723_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.alit.2020.02.002","article-title":"The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol. Int.: Off. J. Japanese Soc. Allergol."},{"key":"10.1016\/j.rmcr.2022.101723_bib11","volume":"vol. 8","author":"Takimoto","year":"2020"},{"key":"10.1016\/j.rmcr.2022.101723_bib12","first-page":"161","volume":"vol. 47","author":"Robinson","year":"2017"},{"issue":"1","key":"10.1016\/j.rmcr.2022.101723_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0091-6749(84)90089-7","article-title":"Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis","volume":"74","author":"Ricketti","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmcr.2022.101723_bib14","first-page":"1757","volume":"vol. 14","author":"Kariyawasam","year":"2020"},{"key":"10.1016\/j.rmcr.2022.101723_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2016.11.019","article-title":"Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature","volume":"122","author":"Li","year":"2017","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.rmcr.2022.101723_bib16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.chest.2019.02.403","article-title":"CT and functional MRI to evaluate airway mucus in severe asthma","volume":"155","author":"Svenningsen","year":"2019","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmcr.2022.101723_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211053156","article-title":"Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target","volume":"50","author":"Jin","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.rmcr.2022.101723_bib18","first-page":"267","volume":"vol. 50","author":"Patel","year":"2020"},{"issue":"17","key":"10.1016\/j.rmcr.2022.101723_bib19","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2169\/internalmedicine.6679-20","article-title":"Successful treatment of mepolizumab- and prednisolone-resistant allergic bronchopulmonary aspergillosis with dupilumab","volume":"60","author":"Mikura","year":"2021","journal-title":"Inten. Med (Tokyo, Japan)"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007122001459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007122001459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:05:29Z","timestamp":1761959129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007122001459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":19,"alternative-id":["S2213007122001459"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2022.101723","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: A case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2022.101723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101723"}}